This is a must read If you cannot see this email properly, please click [here]( Sponsor [Weiss issues 'Buy' on AI sleeper stock](
Based on our Weiss Ratings, we’ve issued a “Buy” on an under-the-radar AI stock. [And we share the details at our Artificial Intelligence Town Hall ….](
--------------------------------------------------------------- Dear Reader, We just ran our screens and wanted to point out 6 'Strong Buy' Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks. See the list below. --------------------------------------------------------------- Sponsor [Best way to buy gold today (not what you'd think)](
so many strange events happening across the economy (longest bear market for bonds since Civil War... unprecedented bank closures... and soaring prices) – it's no wonder the richest investors are loading up on gold. But what you might not realize is there's a much better way to profit from rising gold prices – without ever touching an ETF, mining stock, or even bullion. [Full details here.](
--------------------------------------------------------------- [Longboard Pharmaceuticals, LBPH]( - Buy to Strong Buy
Our research shows that [Longboard Pharmaceuticals]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $34.80. The target pricing ranges from a high forecast of $55 down to a low forecast of $13. [Longboard Pharmaceuticals (LBPH)](’s last closing price was $22.4 which would put the average price target at 53.57% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Strong Buy
- Yahoo! Finance: Bullish
- Barchart.com: buy
[Click for chart >>]( [McKesson, MCK]( - Buy to Strong Buy
Our research shows that [McKesson]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $528.40. The target pricing ranges from a high forecast of $563 down to a low forecast of $502. [McKesson (MCK)](’s last closing price was $483.27 which would put the average price target at 5.32% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Strong Buy
- Yahoo! Finance: Bullish
- Barchart.com: Strong buy
[Click for chart >>]( --------------------------------------------------------------- Sponsor [AI "wealth window" will close January 9, 2024?](
Next-generation AI technology will create the first $100 TRILLION industry. AI 2.0 will open a brief “wealth window”… That will slam shut January 9, 2024. [>>HERE is everything you need now<<](
--------------------------------------------------------------- [OmniAb, OABI]( - Buy to Strong Buy
Our research shows that [OmniAb]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $9.00. The target pricing ranges from a high forecast of $8 down to a low forecast of $10. [OmniAb (OABI)](’s last closing price was $6.36 which would put the average price target at 44.18% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Strong Buy
- Yahoo! Finance: Bullish
- Barchart.com: Strong buy [Click for chart >>]( [PGT, PGTI]( - Buy to Strong Buy
Our research shows that [PGT]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $39.75. The target pricing ranges from a high forecast of $42 down to a low forecast of $37. [PGT (PGTI)](’s last closing price was $41.38 which would put the average price target at -3.94% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Strong Buy
- Yahoo! Finance: Bearish
- Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [[BREAKING] New "Living Software" to Revolutionize Warfare]( This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley [Get the name of the company supplying it to the U.S. Army here ](
--------------------------------------------------------------- [Regeneron, REGN]( - Buy to Strong Buy
Our research shows that [Regeneron]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $979.00. The target pricing ranges from a high forecast of $980 down to a low forecast of $1060. [Regeneron (REGN)](’s last closing price was $912.82 which would put the average price target at 2.70% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Strong Buy
- Yahoo! Finance: Bearish
- Barchart.com: Strong buy [Click for chart >>]( [Silence Therapeutics, SLN]( - Buy to Strong Buy
Our research shows that [Silence Therapeutics]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $37.80. The target pricing ranges from a high forecast of $75 down to a low forecast of $15. [Silence Therapeutics (SLN)](’s last closing price was $18.51 which would put the average price target at 108.91% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Strong Buy
- Yahoo! Finance: Bearish
- Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [3 dividend stocks with 6-figures potential for 2024](
In 2014, I quietly released 3 high-yield dividend stocks to a small group of dividend investors like yourself. Fast forward a decade later…And those 3 dividend stock would have thrown off over $671,727 in dividends if you had started with an average sized IRA portfolio. That's an average of $5,597 in income each month earned. Plus you didn't sell one single share! Well, big news...I'm releasing my next 3 dividend stocks to buy and hold for the NEXT decade. [Discover how to get them here.](
--------------------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. To your financial freedom! The Editor DailyMarketMovers.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to DailyMarketMoverscom [If you are not a human, click here.]( DailyMarketMovers.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software